Center for Cancer Immune Therapy (CCIT), Department of Hematology, 54P4, Copenhagen University Hospital, Herlev, Denmark.
Leukemia. 2013 Dec;27(12):2332-40. doi: 10.1038/leu.2013.196. Epub 2013 Jul 1.
Tumor-infiltrating CD4+CD25+ regulatory T cells (Tregs) are associated with an impaired prognosis in several cancers. The transcription factor forkhead box P3 (Foxp3) is generally expressed in Tregs. Here, we identify and characterize spontaneous cytotoxic immune responses to Foxp3-expressing cells in peripheral blood of healthy volunteers and cancer patients. These immune responses were directed against a HLA-A2-restricted peptide epitope derived from Foxp3. Foxp3-reactive T cells were characterized as cytotoxic CD8+ T cells. These cells recognized dendritic cells incubated with recombinant Foxp3 protein indicating that this protein was indeed internalized, processed and cross-presented in the context of HLA-A2. More importantly, however, Foxp3-specific T cells were able to specifically recognize Tregs. Similarly, Foxp3+ malignant T cells established from a Cutaneous T-cell lymphomas (CTCL) patient were readily killed by the Foxp3-specific cytotoxic T lymphocytes. The spontaneous presence of Foxp3-specific cytotoxic T-cell responses suggest a general role of such T cells in the complex network of immune regulation as such responses may eliminate Tregs, that is, suppression of the suppressors. Consequently, induction of Foxp3-specific cytotoxic T-cell responses appears as an attractive tool to boost spontaneous or therapeutically provoked immune responses, for example, for the therapy of cancer.
肿瘤浸润性 CD4+CD25+调节性 T 细胞(Tregs)与几种癌症的预后不良有关。转录因子叉头框 P3(Foxp3)通常在 Tregs 中表达。在这里,我们鉴定并描述了健康志愿者和癌症患者外周血中 Foxp3 表达细胞的自发细胞毒性免疫反应。这些免疫反应针对 Foxp3 衍生的 HLA-A2 限制性肽表位。Foxp3 反应性 T 细胞被鉴定为细胞毒性 CD8+T 细胞。这些细胞识别用重组 Foxp3 蛋白孵育的树突状细胞,表明该蛋白确实被内化、加工并在 HLA-A2 背景下交叉呈递。然而,更重要的是,Foxp3 特异性 T 细胞能够特异性识别 Tregs。同样,从皮肤 T 细胞淋巴瘤(CTCL)患者建立的 Foxp3+恶性 T 细胞也容易被 Foxp3 特异性细胞毒性 T 淋巴细胞杀死。Foxp3 特异性细胞毒性 T 细胞反应的自发存在表明这些 T 细胞在复杂的免疫调节网络中具有普遍作用,因为这些反应可能会消除 Tregs,即抑制抑制物。因此,诱导 Foxp3 特异性细胞毒性 T 细胞反应似乎是增强自发或治疗性引发的免疫反应的一种有吸引力的工具,例如用于癌症的治疗。